Literature DB >> 11485855

Cell proliferation in the growing human heart: MIB-1 immunostaining in preterm and term infants at autopsy.

Y Huttenbach1, M L Ostrowski, D Thaller, H S Kim.   

Abstract

Few studies of human cardiac myocyte proliferation in the perinatal period have been conducted. We measured the proliferative activity of left ventricular myocytes in tissue obtained at autopsy in three surgically induced abortuses, 20 preterm infants with gestational ages ranging from 12 to 35 weeks, eight term infants with ages ranging from 1 day to 11 months, and five adults. The preterm infants lived less than 24 h, thus simulating the in utero condition of developing hearts. To assess the proliferative activity of the myocytes, we measured immunoreactivity using the monoclonal antibody MIB-1 against the recombinant Ki-67 nuclear antigen. Immunostained sections were examined by light microscopy, and the results expressed as a staining index (SI) of 0-3, according to the percentage of positively stained myocyte nuclei. Myocyte proliferative activity remained constant during the early preterm period and decreased in the late preterm and early postterm periods. Adult myocytes, regardless of cardiac weight, did not reveal proliferative activity as assessed by immunostaining. This proliferation pattern is consistent with findings in most earlier studies in animal models.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485855     DOI: 10.1016/s1054-8807(01)00065-5

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  13 in total

1.  Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes.

Authors:  Katrina A Bicknell; Carmen H Coxon; Gavin Brooks
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

2.  Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway.

Authors:  Todd C McDevitt; Michael A Laflamme; Charles E Murry
Journal:  J Mol Cell Cardiol       Date:  2005-10-19       Impact factor: 5.000

3.  miR-1, miR-133a/b, and miR-208a in human fetal hearts correlate to the apoptotic and proliferation markers.

Authors:  Emanuela Boštjančič; Maja Jerše; Damjan Glavač; Nina Zidar
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-14

4.  Impact of preterm birth on the developing myocardium of the neonate.

Authors:  Jonathan G Bensley; Lynette Moore; Robert De Matteo; Richard Harding; Mary Jane Black
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

Review 5.  Endocrine and other physiologic modulators of perinatal cardiomyocyte endowment.

Authors:  S S Jonker; S Louey
Journal:  J Endocrinol       Date:  2015-10-02       Impact factor: 4.286

Review 6.  Postnatal Cardiac Development and Regenerative Potential in Large Mammals.

Authors:  Nivedhitha Velayutham; Emma J Agnew; Katherine E Yutzey
Journal:  Pediatr Cardiol       Date:  2019-07-25       Impact factor: 1.655

7.  Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep.

Authors:  Sonnet S Jonker; George D Giraud; Eileen I Chang; Miriam R Elman; Samantha Louey
Journal:  FASEB J       Date:  2020-06-23       Impact factor: 5.191

8.  Moderate preterm birth affects right ventricular structure and function and pulmonary artery blood flow in adult sheep.

Authors:  Marshall M Mrocki; Vivian B Nguyen; Paul Lombardo; Megan R Sutherland; Jonathan G Bensley; Ilias Nitsos; Beth J Allison; Richard Harding; Robert De Matteo; Michal Schneider; Graeme R Polglase; M Jane Black
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

9.  IUGR impairs cardiomyocyte growth and maturation in fetal sheep.

Authors:  Sonnet S Jonker; Daniel Kamna; Dan LoTurco; Jenai Kailey; Laura D Brown
Journal:  J Endocrinol       Date:  2018-10-16       Impact factor: 4.286

10.  Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro.

Authors:  Carmen H Coxon; Katrina A Bicknell; Fleur L Moseley; Gavin Brooks
Journal:  PLoS One       Date:  2009-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.